Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada
Abstract Background: Benzodiazepines are a class of medications that are being frequently prescribed in Canada but carry significant risk of…
affective and anxiety
Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders
Abstract Mental disorders account for one of the most prevalent categories of the burden of disease worldwide, with depression expected…
Cannabidiol usage, efficacy, and side effects: analyzing the impact of health conditions, medications, and cannabis use in a cross-sectional online pilot study
Abstract Background: Products containing cannabidiol (CBD) are attracting attention because of their potential therapeutic benefits and positive impacts on well-being…
Cannabis and Anxiety: A Critical Review
Abstract Introduction: Cannabis has been reported to have both anxiogenic and anxiolytic effects. Habitual cannabis use has been associated with…
Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study
Abstract Background: There is ongoing uncertainty about whether cannabis use increases the risk of developing an anxiety disorder. In this…
Is cannabidiol (CBD) effective to ease separation anxiety?
Abstract CBD is the primary noneuphorizing and nonaddictive compound of cannabis. It has recently been shown to possess considerable therapeutic…
UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients
Abstract This study aims to analyze changes in health-related quality of life (HRQoL) and safety in patients with generalized anxiety…
The impact of cannabidiol placebo on responses to an acute stressor: A replication and proof of concept study
Abstract Background: Our group has previously reported that cannabidiol (CBD) expectancy alone blunts markers of stress, particularly during anticipation, but…
Behavioral or neuropsychiatric symptoms of Alzheimer’s disease: from psychopathology to pharmacological management
Abstract Neuropsychiatric or behavioral symptoms of dementia encompass a series of disorders, such as anxiety, depression, apathy, psychosis, and agitation,…
A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance
Abstract Background: Research on cannabis‐based medicinal products (CBMPs) in anxiety remains inconclusive due to a paucity of high‐quality evidence. Studies…